NEW YORK, March 24, 2023 /PRNewswire/ — The non-hodgkin lymphoma therapeutics market size is forecast to grow by USD 5,427.51 million between 2022 and 2027, and the growth momentum will be accelerating at a CAGR of 8.14% during the forecast period. Growing awareness about cancer is…